Jim Simons
ALGS icon

Jim Simons’s Aligos Therapeutics ALGS Stock Holding History

Jim Simons’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$746K Buy
100,450
+15,006
+18% +$114K ﹤0.01% 2413
2025
Q4 		$796K Buy
85,444
+30,425
+55% +$287K ﹤0.01% 2380
2025
Q3 		$539K Buy
55,019
+2,475
+5% +$22.6K ﹤0.01% 2756
2025
Q2 		$379K Buy
52,544
+12,968
+33% +$77.6K ﹤0.01% 2967
2025
Q1 		$327K Buy
39,576
+28,133
+246% +$617K ﹤0.01% 2901
2024
Q4 		$456K Sell
11,443
-2,000
-15% -$38.6K ﹤0.01% 2885
2024
Q3 		$116K Sell
13,443
-17,311
-56% -$215K ﹤0.01% 3232
2024
Q2 		$269K Sell
30,754
-1,576
-5% -$27.7K ﹤0.01% 2949
2024
Q1 		$792K Buy
32,330
+12,732
+65% +$254K ﹤0.01% 2632
2023
Q4 		$325K Buy
19,598
+6,744
+52% +$116K ﹤0.01% 2954
2023
Q3 		$240K Sell
12,854
-4,368
-25% -$96.8K ﹤0.01% 3026
2023
Q2 		$418K Sell
17,222
-892
-5% -$23.9K ﹤0.01% 2971
2023
Q1 		$396K Sell
18,114
-3,176
-15% -$121K ﹤0.01% 2995
2022
Q4 		$507K Sell
21,290
-7,934
-27% -$200K ﹤0.01% 2941
2022
Q3 		$804K Sell
29,224
-6,900
-19% -$229K ﹤0.01% 2630
2022
Q2 		$1.09M Buy
36,124
+21,631
+149% +$735K ﹤0.01% 2649
2022
Q1 		$779K Buy
14,493
+12,313
+565% +$986K ﹤0.01% 2887
2021
Q4 		$647K Buy
2,180
+52
+2% +$19K ﹤0.01% 2957
2021
Q3 		$825K Buy
+2,128
New +$842K ﹤0.01% 2654

Other funds holding ALGS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Jim Simons's ALGS Position: Q1 2026 in Review

Jim Simons increased its Aligos Therapeutics (ALGS) stake by 18% in Q1 2026, buying an estimated $114K and bringing the position to 100,450 shares worth $746K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Jim Simons first reported a position in ALGS in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.09M in Q2 2022. 35 funds tracked by Wall St. Rank hold ALGS as of Q1 2026.

  • Jim Simons held 100,450 shares of Aligos Therapeutics worth $746K as of Q1 2026.
  • Jim Simons bought 15,006 Aligos Therapeutics shares in Q1 2026, an estimated $114K.
  • Aligos Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2413 holding.
  • Jim Simons first reported a position in Aligos Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Jim Simons's Aligos Therapeutics position peaked at $1.09M in Q2 2022.
  • 35 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.